Phosphodiesterase inhibitors

Intervention

1 paper2 findings

  • 1 lab in 1 country
  • Funder: ZonMw

Outcomes

2

Microvascular perfusion

upin other1

1 study
  1. Phosphodiesterase inhibitors improve microvascular perfusion in other (0.76 [0.28; 1.25]).

    “PDE inhibitors enhanced SNP-induced vasorelaxation (0.5 [0.04; 0.96], n = 5) and microvascular perfusion (0.76 [0.28; 1.25], n = 4)”

    Reviewin aged animal models of vascular dysfunction

    Targeting the NO-cGMP axis in age-related vascular dysfunction: a systematic review and meta-analysis of preclinical animal studies

    GeroScience4 Aug 2026

SNP-induced vasorelaxation

upin other1

1 study
  1. Phosphodiesterase inhibitors improve SNP-induced vasorelaxation in other (0.5 [0.04; 0.96]).

    “PDE inhibitors enhanced SNP-induced vasorelaxation (0.5 [0.04; 0.96], n = 5)”

    Reviewin aged animal models of vascular dysfunction

    Targeting the NO-cGMP axis in age-related vascular dysfunction: a systematic review and meta-analysis of preclinical animal studies

    GeroScience4 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months